Juvenile Dermatomyositis Latest Advances

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Journal: Lupus

Published: May 05, 2026

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.

Journal: The Journal of rheumatology

Published: April 15, 2026

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Journal: Cureus

Published: February 16, 2026

Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.

Journal: Medicina (Kaunas, Lithuania)

Published: February 07, 2026

Update on clinimetric assessments in juvenile dermatomyositis: conceptual foundations, current tools, and future directions : (Narrative review describing the development, validation, and application of clinimetric outcome measures in juvenile dermatomyositis).

Journal: Pediatric rheumatology online journal

Published: February 06, 2026

Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study.

Journal: Pediatric rheumatology online journal

Published: February 01, 2026

Benign Acute Childhood Myositis Before and After COVID-19: A Nine-Year Retrospective Study.

Journal: Pediatric reports

Published: February 01, 2026

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Journal: Rheumatology advances in practice

Published: January 19, 2026

Long-term outcomes and prognostic factors in juvenile dermatomyositis: A systematic review of studies with more than 12 months of follow-up.

Journal: Autoimmunity reviews

Published: December 30, 2025

Case Report: Juvenile dermatomyositis complicated by acute myeloid leukemia: achievement of sustained remission through hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: December 27, 2025

Use of the EOS 2D/3D Imaging System for the Evaluation of Calcinosis in Juvenile Dermatomyositis: A Retrospective Case Series.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: December 23, 2025

Juvenile Dermatomyositis Latest Advances

Find the Latest Research About Juvenile Dermatomyositis

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.

Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.

Update on clinimetric assessments in juvenile dermatomyositis: conceptual foundations, current tools, and future directions : (Narrative review describing the development, validation, and application of clinimetric outcome measures in juvenile dermatomyositis).

Update on clinimetric assessments in juvenile dermatomyositis: conceptual foundations, current tools, and future directions : (Narrative review describing the development, validation, and application of clinimetric outcome measures in juvenile dermatomyositis).

Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study.

Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study.

Benign Acute Childhood Myositis Before and After COVID-19: A Nine-Year Retrospective Study.

Benign Acute Childhood Myositis Before and After COVID-19: A Nine-Year Retrospective Study.

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Long-term outcomes and prognostic factors in juvenile dermatomyositis: A systematic review of studies with more than 12 months of follow-up.

Long-term outcomes and prognostic factors in juvenile dermatomyositis: A systematic review of studies with more than 12 months of follow-up.

Case Report: Juvenile dermatomyositis complicated by acute myeloid leukemia: achievement of sustained remission through hematopoietic stem cell transplantation.

Case Report: Juvenile dermatomyositis complicated by acute myeloid leukemia: achievement of sustained remission through hematopoietic stem cell transplantation.

Use of the EOS 2D/3D Imaging System for the Evaluation of Calcinosis in Juvenile Dermatomyositis: A Retrospective Case Series.

Use of the EOS 2D/3D Imaging System for the Evaluation of Calcinosis in Juvenile Dermatomyositis: A Retrospective Case Series.